These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28339786)

  • 1. Modelling original antigenic sin in dengue viral infection.
    Nikin-Beers R; Ciupe SM
    Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.
    Elong Ngono A; Chen HW; Tang WW; Joo Y; King K; Weiskopf D; Sidney J; Sette A; Shresta S
    EBioMedicine; 2016 Nov; 13():284-293. PubMed ID: 27746192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-depth analysis of original antigenic sin in dengue virus infection.
    Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; Cowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR
    J Virol; 2011 Jan; 85(1):410-21. PubMed ID: 20980526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
    Appanna R; Huat TL; See LL; Tan PL; Vadivelu J; Devi S
    Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte responses to heterologous secondary dengue virus infections.
    Rothman AL
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
    Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antibody in enhancing dengue virus infection.
    Nikin-Beers R; Ciupe SM
    Math Biosci; 2015 May; 263():83-92. PubMed ID: 25707916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
    Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
    Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial cross-enhancement in models for dengue epidemiology.
    Woodall H; Adams B
    J Theor Biol; 2014 Jun; 351():67-73. PubMed ID: 24568780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-Cell mediated adaptive immunity and antibody-dependent enhancement in secondary dengue infection.
    Sasmal SK; Takeuchi Y; Nakaoka S
    J Theor Biol; 2019 Jun; 470():50-63. PubMed ID: 30878699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
    Chaudhury S; Gromowski GD; Ripoll DR; Khavrutskii IV; Desai V; Wallqvist A
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic Model of the Adaptive Immune Response Predicts Disease Severity and Captures Enhanced Cross-Reactivity in Natural Dengue Infections.
    Nguyen HD; Chaudhury S; Waickman AT; Friberg H; Currier JR; Wallqvist A
    Front Immunol; 2021; 12():696755. PubMed ID: 34484195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses.
    Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
    Microbes Infect; 2007 Jul; 9(8):940-6. PubMed ID: 17544804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Heterotypic DENV-specific CD8
    Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
    EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the contribution of cellular immunity to dengue disease pathogenesis.
    Mathew A; Rothman AL
    Immunol Rev; 2008 Oct; 225():300-13. PubMed ID: 18837790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.